A 28 Day Parallel Group Study to Assess the Effects of RDN-929
Clinical trial NCT03963973 · TERMINATED
Trial details
- NCT number
- NCT03963973
- Sponsor
- Alkermes, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2020-01-22
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.